Reaction: Olsalazine to 1 product

Reaction
Reaction type
cleavage
Direction
Major circulating metabolite?
Yes
Spontaneous?
No
Activity
active
References
  1. Wadworth AN, Fitton A: Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease. Drugs. 1991 Apr;41(4):647-64. doi: 10.2165/00003495-199141040-00009. [Article]
  2. FDA Approved Drug Products: DIPENTUM (olsalazine) Oral Capsules (November 2022) [Link]
Comments
Not Available
Enzymes
Not Available